Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva profit plummets, stock slides | Ctech
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - KTSA
What does Teva's growth strategy look like?
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Teva Faces New Class Action—But Could It Afford Another Se...
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
